MONTREAL, QUEBEC--(CCNMatthews - June 5, 2006) - MethylGene Inc. (TSX:MYG) today announced that Donald F. Corcoran, President and Chief Executive Officer of MethylGene, will present at Windhover’s Therapeutics Alliance Oncology Conference in Atlanta at 12:10 p.m., ET on Wednesday, June 7, 2006. Mr. Corcoran will discuss MethylGene’s MGCD0103, which was selected by Windhover as one of the ten leading cancer projects. MGCD0103’s selection is based on results from a survey that polled leading U.S. oncologists for their opinions on the most interesting projects currently in development for the treatment of cancer. The survey was performed by Clinical Advisors, an independent research firm, on behalf of Windhover.
